According to Emergent BioSolutions 's latest financial reports the company's total assets are $1.82 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $1.82 B | -42.42% |
2022-12-31 | $3.16 B | 7.05% |
2021-12-31 | $2.95 B | 2.58% |
2020-12-31 | $2.88 B | 23.89% |
2019-12-31 | $2.32 B | 4.39% |
2018-12-31 | $2.22 B | 108.32% |
2017-12-31 | $1.07 B | 10.32% |
2016-12-31 | $0.97 B | -6.49% |
2015-12-31 | $1.03 B | 10.52% |
2014-12-31 | $0.93 B | 49.8% |
2013-12-31 | $0.62 B | 11.06% |
2012-12-31 | $0.56 B | 3.18% |
2011-12-31 | $0.54 B | 9.3% |
2010-12-31 | $0.50 B | 45.15% |
2009-12-31 | $0.34 B | 18.54% |
2008-12-31 | $0.29 B | 6.32% |
2007-12-31 | $0.27 B | 14.8% |
2006-12-31 | $0.23 B | 137.47% |
2005-12-31 | $0.10 B | 45.29% |
2004-12-31 | $69.05 M | |
2002-12-31 | $22.79 M | -10.36% |
2001-12-31 | $25.42 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $226.50 B | 12,323.27% | ๐บ๐ธ USA |
Merck MRK | $106.67 B | 5,750.98% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $75.11 B | 4,019.87% | ๐ฌ๐ง UK |
Soligenix SNGX | $9.79 M | -99.46% | ๐บ๐ธ USA |
SIGA Technologies SIGA | $0.25 B | -86.05% | ๐บ๐ธ USA |
Celldex Therapeutics CLDX | $0.46 B | -74.46% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $43.47 B | 2,284.76% | ๐ฎ๐ฑ Israel |